Rosalinda Madonna Selected Research

Percutaneous Coronary Intervention

1/2021	Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
10/2016	Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalinda Madonna Research Topics

Disease

21	Cardiotoxicity 01/2022 - 07/2015
16	Heart Failure 07/2022 - 02/2010
16	Neoplasms (Cancer) 05/2021 - 09/2015
15	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2006
12	Atherosclerosis 01/2021 - 11/2004
11	Ischemia 11/2019 - 07/2011
7	Myocardial Ischemia (Ischemic Heart Diseases) 07/2022 - 05/2013
7	Cardiomyopathies (Cardiomyopathy) 05/2021 - 09/2015
7	Myocardial Infarction 01/2021 - 09/2003
7	Reperfusion Injury 11/2019 - 04/2013
5	Infarction (Infarctions) 01/2021 - 02/2010
5	Inflammation (Inflammations) 01/2020 - 04/2005
4	Heart Diseases (Heart Disease) 01/2022 - 04/2005
4	Fibrosis (Cirrhosis) 11/2020 - 10/2014
3	Left Ventricular Dysfunction 01/2022 - 05/2016
3	Hypertension (High Blood Pressure) 01/2021 - 05/2016
3	Insulin Resistance 01/2020 - 02/2009
3	Hyperglycemia 01/2020 - 03/2011
3	Hyperinsulinism (Hyperinsulinemia) 03/2011 - 09/2008
2	COVID-19 10/2022 - 01/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2022 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 02/2009
2	Pulmonary Hypertension 01/2021 - 10/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 01/2017
2	Vascular Diseases (Vascular Disease) 06/2017 - 10/2016
2	ST Elevation Myocardial Infarction 05/2017 - 01/2017
2	Thrombosis (Thrombus) 05/2016 - 05/2016
2	Leukemia 05/2016 - 05/2016
2	Edema (Dropsy) 05/2014 - 01/2012
2	Acidosis 05/2013 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 03/2011 - 02/2009
2	Critical Illness (Critically Ill) 07/2010 - 09/2008
2	Sudden Death 09/2003 - 03/2002
1	Disease Progression 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Infections 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2020

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 01/2021 - 08/2012
9	AnthracyclinesIBA 01/2021 - 01/2016
8	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2015
6	CytokinesIBA 01/2021 - 11/2004
6	Biological ProductsIBA 04/2019 - 11/2004
5	Insulin (Novolin)FDA Link 01/2020 - 09/2008
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
3	ponatinibIBA 01/2022 - 03/2020
3	myocardinIBA 12/2020 - 09/2013
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2020 - 05/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 10/2013
3	LipidsIBA 01/2019 - 10/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 04/2005
3	erucylphosphocholineIBA 10/2017 - 10/2016
3	ErbB Receptors (EGF Receptor)IBA 05/2016 - 09/2015
3	Protons (Proton)IBA 05/2014 - 01/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2013 - 07/2011
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2006 - 03/2002
2	Tyrosine Kinase InhibitorsIBA 05/2021 - 03/2020
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2020
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 10/2016
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2012
2	CholesterolIBA 04/2018 - 04/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2016 - 05/2016
2	Growth Factor ReceptorsIBA 05/2016 - 05/2016
2	Cardiotonic Agents (Cardiac Stimulants)IBA 05/2016 - 05/2016
2	Angiogenesis InhibitorsIBA 05/2016 - 05/2016
2	Proteasome InhibitorsIBA 05/2016 - 05/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015 - 08/2012
2	Sodium-Hydrogen ExchangersIBA 01/2015 - 11/2013
2	Streptozocin (Streptozotocin)FDA Link 05/2014 - 01/2012
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022
1	C-Reactive ProteinIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Connexin 43 (Connexin43)IBA 05/2021
1	ConnexinsIBA 05/2021
1	Connexin 26IBA 05/2021
1	trans-crotonin (CTN)IBA 01/2021
1	CobicistatIBA 01/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	TroponinIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	empagliflozinIBA 11/2020
1	Sodium-Glucose Transport ProteinsIBA 11/2020
1	Colchicine FDA LinkGeneric 01/2020
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2020
1	canakinumab FDA Link 01/2020
1	Estrogens (Estrogen)FDA Link 11/2019
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2019
1	Hormones (Hormone)IBA 04/2019

Therapy/Procedure

34	Therapeutics 07/2022 - 04/2005
4	Drug Therapy (Chemotherapy) 01/2017 - 09/2015
4	Transplantation 10/2015 - 01/2012
2	Art Therapy 01/2021 - 04/2013
2	Percutaneous Coronary Intervention 01/2021 - 10/2016
2	Stents 10/2017 - 10/2016
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2017 - 01/2017
2	Secondary Prevention 05/2016 - 05/2016
2	Precision Medicine 05/2016 - 05/2016
2	Glycemic Control 07/2010 - 09/2008